Profile change history

What changed for Teduglutide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Teduglutide identity.

58Total events
58Record additions
0Version changes
12Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 58 connected records →

Showing the latest 58 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00072839

PeptideScanner retained ClinicalTrials.gov record NCT00072839 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-25, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 25, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00081458

PeptideScanner retained ClinicalTrials.gov record NCT00081458 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 9, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00172185

PeptideScanner retained ClinicalTrials.gov record NCT00172185 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-02, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 2, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00308438

PeptideScanner retained ClinicalTrials.gov record NCT00308438 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-14, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 14, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00798967

PeptideScanner retained ClinicalTrials.gov record NCT00798967 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-03, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 3, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00819468

PeptideScanner retained ClinicalTrials.gov record NCT00819468 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-14, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 14, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00930644

PeptideScanner retained ClinicalTrials.gov record NCT00930644 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-11, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 11, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01028768

PeptideScanner retained ClinicalTrials.gov record NCT01028768 at 2026-11-15T21:55:23.600Z. Its registry update date was 2012-05-07, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 7, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01028924

PeptideScanner retained ClinicalTrials.gov record NCT01028924 at 2026-11-15T21:55:23.600Z. Its registry update date was 2012-05-07, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 7, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01209351

PeptideScanner retained ClinicalTrials.gov record NCT01209351 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-04, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 4, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01560403

PeptideScanner retained ClinicalTrials.gov record NCT01560403 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-10, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 10, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01952080

PeptideScanner retained ClinicalTrials.gov record NCT01952080 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 9, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02099084

PeptideScanner retained ClinicalTrials.gov record NCT02099084 at 2026-11-15T21:55:23.600Z. Its registry update date was 2016-02-22, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
February 22, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02340819

PeptideScanner retained ClinicalTrials.gov record NCT02340819 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 9, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02431325

PeptideScanner retained ClinicalTrials.gov record NCT02431325 at 2026-11-15T21:55:23.600Z. Its registry update date was 2023-06-12, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 12, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02889393

PeptideScanner retained ClinicalTrials.gov record NCT02889393 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-10-06, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
October 6, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02949362

PeptideScanner retained ClinicalTrials.gov record NCT02949362 at 2026-11-15T21:55:23.600Z. Its registry update date was 2025-03-19, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
March 19, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02980666

PeptideScanner retained ClinicalTrials.gov record NCT02980666 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-02-02, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
February 2, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03268811

PeptideScanner retained ClinicalTrials.gov record NCT03268811 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-05-24, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 24, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03422666

PeptideScanner retained ClinicalTrials.gov record NCT03422666 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-06-14, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
June 14, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03442972

PeptideScanner retained ClinicalTrials.gov record NCT03442972 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-05-25, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 25, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03562130

PeptideScanner retained ClinicalTrials.gov record NCT03562130 at 2026-11-15T21:55:23.600Z. Its registry update date was 2025-09-11, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
September 11, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03571516

PeptideScanner retained ClinicalTrials.gov record NCT03571516 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-11, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 11, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03596164

PeptideScanner retained ClinicalTrials.gov record NCT03596164 at 2026-11-15T21:55:23.600Z. Its registry update date was 2023-03-15, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
March 15, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03663582

PeptideScanner retained ClinicalTrials.gov record NCT03663582 at 2026-11-15T21:55:23.600Z. Its registry update date was 2020-08-04, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
August 4, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03716115

PeptideScanner retained ClinicalTrials.gov record NCT03716115 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-09-27, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
September 27, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04290429

PeptideScanner retained ClinicalTrials.gov record NCT04290429 at 2026-11-15T21:55:23.600Z. Its registry update date was 2023-11-29, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
November 29, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04465396

PeptideScanner retained ClinicalTrials.gov record NCT04465396 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-10-04, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
October 4, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05027308

PeptideScanner retained ClinicalTrials.gov record NCT05027308 at 2026-11-15T21:55:23.600Z. Its registry update date was 2024-05-16, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 16, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06973304

PeptideScanner retained ClinicalTrials.gov record NCT06973304 at 2026-11-15T21:55:23.600Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
September 8, 2026
Evidence lane
Clinical trials
Record added

Federal Register notice 2012-20612

The Federal Register published notice 2012-20612, attributed to FDA and its parent HHS department, on 2012-08-22. Its official title is “Gastrointestinal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
August 22, 2012
Evidence lane
Regulatory
Record added

Federal Register notice 2015-11000

The Federal Register published notice 2015-11000, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; GATTEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 7, 2015
Evidence lane
Regulatory
Record added

Federal Register notice 2024-16618

The Federal Register published notice 2024-16618, attributed to FDA and its parent HHS department, on 2024-07-29. Its official title is “Pediatric Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
July 29, 2024
Evidence lane
Regulatory
Record added

Teduglutide for the Treatment of Short Bowel Syndrome.

PubMed lists PMID 24871569 in The Annals of pharmacotherapy as Review, Journal Article, with publication-date metadata of 2014-05-28 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 20, 2019
Evidence lane
Literature metadata
Record added

Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide.

PubMed lists PMID 27507402 in JPEN. Journal of parenteral and enteral nutrition as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-08-09 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 13, 2018
Evidence lane
Literature metadata
Record added

Teduglutide in Patients With Active Crohn's Disease and Short Bowel Syndrome.

PubMed lists PMID 30990222 in Inflammatory bowel diseases as Case Reports, Letter, with publication-date metadata of 2019-08-20 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 1, 2020
Evidence lane
Literature metadata
Record added

Accelerated Colorectal Polyposis in an Immunosuppressed Patient With a Small Bowel Transplant Treated With Teduglutide: Case Report and Review of Literature.

PubMed lists PMID 31176580 in Clinical colorectal cancer as Case Reports, Journal Article, Review, with publication-date metadata of 2019-03-11 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 29, 2020
Evidence lane
Literature metadata
Record added

Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.

PubMed lists PMID 31423614 in JPEN. Journal of parenteral and enteral nutrition as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-08-18 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 12, 2021
Evidence lane
Literature metadata
Record added

Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.

PubMed lists PMID 31522784 in Clinical nutrition (Edinburgh, Scotland) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-08-23 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 16, 2021
Evidence lane
Literature metadata
Record added

Comprehensive nutritional assessment in short bowel syndrome with chronic renal failure on teduglutide therapy: A case report.

PubMed lists PMID 32088500 in Nutrition (Burbank, Los Angeles County, Calif.) as Case Reports, Journal Article, with publication-date metadata of 2020-01-07 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 23, 2021
Evidence lane
Literature metadata
Record added

Teduglutide for short bowel syndrome.

PubMed lists PMID 32346219 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2020-03-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 28, 2020
Evidence lane
Literature metadata
Record added

Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.

PubMed lists PMID 32804906 in Journal of pediatric gastroenterology and nutrition as Journal Article, with publication-date metadata of 2020-12 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 20, 2021
Evidence lane
Literature metadata
Record added

Teduglutide Therapy in 2 Patients With Short-Bowel Syndrome and Familial Adenomatous Polyposis.

PubMed lists PMID 32829492 in JPEN. Journal of parenteral and enteral nutrition as Case Reports, Journal Article, with publication-date metadata of 2020-09-07 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 8, 2021
Evidence lane
Literature metadata
Record added

Hernia enlargement and pancreatitis in a patient with short bowel syndrome treated with teduglutide.

PubMed lists PMID 34903028 in Nutricion hospitalaria as Case Reports, Journal Article, with publication-date metadata of 2022-02-09 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 1, 2022
Evidence lane
Literature metadata
Record added

Teduglutide in pediatric intestinal failure: A position statement of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP).

PubMed lists PMID 35654733 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Journal Article, Review, Consensus Statement, with publication-date metadata of 2022-05-31 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Use of teduglutide for short bowel syndrome and Crohn's disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy.

PubMed lists PMID 36177820 in Revista espanola de enfermedades digestivas as Case Reports, Journal Article, with publication-date metadata of 2023-06 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.

PubMed lists PMID 37001195 in Clinical nutrition (Edinburgh, Scotland) as Journal Article, with publication-date metadata of 2023-03-18 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Teduglutide for the treatment of short bowel syndrome: a double-edged sword?

PubMed lists PMID 37270286 in The American journal of clinical nutrition as Editorial, Comment, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 16, 2023
Evidence lane
Literature metadata
Record added

Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.

PubMed lists PMID 37270288 in The American journal of clinical nutrition as Journal Article, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.

PubMed lists PMID 37270289 in The American journal of clinical nutrition as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 16, 2023
Evidence lane
Literature metadata
Record added

Expression, Purification and Characterization of Functional Teduglutide Using GST Fusion System in Prokaryotic Cells.

PubMed lists PMID 37646058 in Advanced pharmaceutical bulletin as Journal Article, with publication-date metadata of 2022-12-06 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 31, 2023
Evidence lane
Literature metadata
Record added

Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.

PubMed lists PMID 39125394 in Nutrients as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2024-08-01 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 30, 2025
Evidence lane
Literature metadata
Record added

Management Patterns of Teduglutide Use in Short Bowel Syndrome: A Survey of 70 Healthcare Professionals.

PubMed lists PMID 39519595 in Nutrients as Journal Article, with publication-date metadata of 2024-11-01 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 16, 2024
Evidence lane
Literature metadata
Record added

Short bowel syndrome and d-lactic acidosis: A case report with supplemental home parenteral nutrition and teduglutide.

PubMed lists PMID 40086997 in Endocrinologia, diabetes y nutricion as Case Reports, Journal Article, Review, with publication-date metadata of 2025-03 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 15, 2025
Evidence lane
Literature metadata
Record added

Quality of life and lived experience of patients with short bowel syndrome treated with teduglutide and weaning off home parenteral nutrition: a qualitative analysis of patient diaries.

PubMed lists PMID 40764045 in BMJ open gastroenterology as Journal Article, with publication-date metadata of 2025-08-05 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 21, 2025
Evidence lane
Literature metadata
Record added

Teduglutide treatment during breast feeding in a patient with intestinal failure: a case report.

PubMed lists PMID 40771220 in Frontiers in nutrition as Case Reports, Journal Article, with publication-date metadata of 2025-07-23 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 9, 2025
Evidence lane
Literature metadata
Record added

Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study.

PubMed lists PMID 41647102 in Intestinal Failure (New York, N.Y.) as Journal Article, with publication-date metadata of 2024-11-28 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 8, 2026
Evidence lane
Literature metadata